Report Detail

Other Global Psoriasis Therapeutics Market Size, Status and Forecast 2019-2025

  • RnM3461649
  • |
  • 04 August, 2020
  • |
  • Global
  • |
  • 93 Pages
  • |
  • QYResearch
  • |
  • Other

Psoriasis Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Psoriasis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Astellas Pharma Inc.
AstraZeneca plc
Boehringer Ingelheim GmbH
F. Hofffmann-La Roche
GlaxoSmithKline plc
Merck & Co., Inc.
Valeant Pharmaceuticals International, Inc.
Biocon Limited
Eli Lilly and Company
G & W Laboratories Inc.

Market segment by Type, the product can be split into
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Others
Market segment by Application, split into
Oral
Parenteral
Topical

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Psoriasis Therapeutics Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Psoriasis Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 TNF Inhibitors
    • 1.4.3 PDE4 Inhibitors
    • 1.4.4 Interleukin Blockers
    • 1.4.5 Others
  • 1.5 Market by Application
    • 1.5.1 Global Psoriasis Therapeutics Market Share by Application: 2020 VS 2026
    • 1.5.2 Oral
    • 1.5.3 Parenteral
    • 1.5.4 Topical
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Psoriasis Therapeutics Market Perspective (2015-2026)
  • 2.2 Global Psoriasis Therapeutics Growth Trends by Regions
    • 2.2.1 Psoriasis Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Psoriasis Therapeutics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Psoriasis Therapeutics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Psoriasis Therapeutics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Psoriasis Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Psoriasis Therapeutics Players by Market Size
    • 3.1.1 Global Top Psoriasis Therapeutics Players by Revenue (2015-2020)
    • 3.1.2 Global Psoriasis Therapeutics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Psoriasis Therapeutics Market Concentration Ratio
    • 3.2.1 Global Psoriasis Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Psoriasis Therapeutics Revenue in 2019
  • 3.3 Psoriasis Therapeutics Key Players Head office and Area Served
  • 3.4 Key Players Psoriasis Therapeutics Product Solution and Service
  • 3.5 Date of Enter into Psoriasis Therapeutics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Psoriasis Therapeutics Historic Market Size by Type (2015-2020)
  • 4.2 Global Psoriasis Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Psoriasis Therapeutics Market Size by Application (2015-2020)
  • 5.2 Global Psoriasis Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Psoriasis Therapeutics Market Size (2015-2020)
  • 6.2 Psoriasis Therapeutics Key Players in North America (2019-2020)
  • 6.3 North America Psoriasis Therapeutics Market Size by Type (2015-2020)
  • 6.4 North America Psoriasis Therapeutics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Psoriasis Therapeutics Market Size (2015-2020)
  • 7.2 Psoriasis Therapeutics Key Players in Europe (2019-2020)
  • 7.3 Europe Psoriasis Therapeutics Market Size by Type (2015-2020)
  • 7.4 Europe Psoriasis Therapeutics Market Size by Application (2015-2020)

8 China

  • 8.1 China Psoriasis Therapeutics Market Size (2015-2020)
  • 8.2 Psoriasis Therapeutics Key Players in China (2019-2020)
  • 8.3 China Psoriasis Therapeutics Market Size by Type (2015-2020)
  • 8.4 China Psoriasis Therapeutics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Psoriasis Therapeutics Market Size (2015-2020)
  • 9.2 Psoriasis Therapeutics Key Players in Japan (2019-2020)
  • 9.3 Japan Psoriasis Therapeutics Market Size by Type (2015-2020)
  • 9.4 Japan Psoriasis Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Psoriasis Therapeutics Market Size (2015-2020)
  • 10.2 Psoriasis Therapeutics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Psoriasis Therapeutics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Psoriasis Therapeutics Market Size by Application (2015-2020)

11 India

  • 11.1 India Psoriasis Therapeutics Market Size (2015-2020)
  • 11.2 Psoriasis Therapeutics Key Players in India (2019-2020)
  • 11.3 India Psoriasis Therapeutics Market Size by Type (2015-2020)
  • 11.4 India Psoriasis Therapeutics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Psoriasis Therapeutics Market Size (2015-2020)
  • 12.2 Psoriasis Therapeutics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Psoriasis Therapeutics Market Size by Type (2015-2020)
  • 12.4 Central & South America Psoriasis Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Astellas Pharma Inc.
    • 13.1.1 Astellas Pharma Inc. Company Details
    • 13.1.2 Astellas Pharma Inc. Business Overview
    • 13.1.3 Astellas Pharma Inc. Psoriasis Therapeutics Introduction
    • 13.1.4 Astellas Pharma Inc. Revenue in Psoriasis Therapeutics Business (2015-2020))
    • 13.1.5 Astellas Pharma Inc. Recent Development
  • 13.2 AstraZeneca plc
    • 13.2.1 AstraZeneca plc Company Details
    • 13.2.2 AstraZeneca plc Business Overview
    • 13.2.3 AstraZeneca plc Psoriasis Therapeutics Introduction
    • 13.2.4 AstraZeneca plc Revenue in Psoriasis Therapeutics Business (2015-2020)
    • 13.2.5 AstraZeneca plc Recent Development
  • 13.3 Boehringer Ingelheim GmbH
    • 13.3.1 Boehringer Ingelheim GmbH Company Details
    • 13.3.2 Boehringer Ingelheim GmbH Business Overview
    • 13.3.3 Boehringer Ingelheim GmbH Psoriasis Therapeutics Introduction
    • 13.3.4 Boehringer Ingelheim GmbH Revenue in Psoriasis Therapeutics Business (2015-2020)
    • 13.3.5 Boehringer Ingelheim GmbH Recent Development
  • 13.4 F. Hofffmann-La Roche
    • 13.4.1 F. Hofffmann-La Roche Company Details
    • 13.4.2 F. Hofffmann-La Roche Business Overview
    • 13.4.3 F. Hofffmann-La Roche Psoriasis Therapeutics Introduction
    • 13.4.4 F. Hofffmann-La Roche Revenue in Psoriasis Therapeutics Business (2015-2020)
    • 13.4.5 F. Hofffmann-La Roche Recent Development
  • 13.5 GlaxoSmithKline plc
    • 13.5.1 GlaxoSmithKline plc Company Details
    • 13.5.2 GlaxoSmithKline plc Business Overview
    • 13.5.3 GlaxoSmithKline plc Psoriasis Therapeutics Introduction
    • 13.5.4 GlaxoSmithKline plc Revenue in Psoriasis Therapeutics Business (2015-2020)
    • 13.5.5 GlaxoSmithKline plc Recent Development
  • 13.6 Merck & Co., Inc.
    • 13.6.1 Merck & Co., Inc. Company Details
    • 13.6.2 Merck & Co., Inc. Business Overview
    • 13.6.3 Merck & Co., Inc. Psoriasis Therapeutics Introduction
    • 13.6.4 Merck & Co., Inc. Revenue in Psoriasis Therapeutics Business (2015-2020)
    • 13.6.5 Merck & Co., Inc. Recent Development
  • 13.7 Valeant Pharmaceuticals International, Inc.
    • 13.7.1 Valeant Pharmaceuticals International, Inc. Company Details
    • 13.7.2 Valeant Pharmaceuticals International, Inc. Business Overview
    • 13.7.3 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Introduction
    • 13.7.4 Valeant Pharmaceuticals International, Inc. Revenue in Psoriasis Therapeutics Business (2015-2020)
    • 13.7.5 Valeant Pharmaceuticals International, Inc. Recent Development
  • 13.8 Biocon Limited
    • 13.8.1 Biocon Limited Company Details
    • 13.8.2 Biocon Limited Business Overview
    • 13.8.3 Biocon Limited Psoriasis Therapeutics Introduction
    • 13.8.4 Biocon Limited Revenue in Psoriasis Therapeutics Business (2015-2020)
    • 13.8.5 Biocon Limited Recent Development
  • 13.9 Eli Lilly and Company
    • 13.9.1 Eli Lilly and Company Company Details
    • 13.9.2 Eli Lilly and Company Business Overview
    • 13.9.3 Eli Lilly and Company Psoriasis Therapeutics Introduction
    • 13.9.4 Eli Lilly and Company Revenue in Psoriasis Therapeutics Business (2015-2020)
    • 13.9.5 Eli Lilly and Company Recent Development
  • 13.10 G & W Laboratories Inc.
    • 13.10.1 G & W Laboratories Inc. Company Details
    • 13.10.2 G & W Laboratories Inc. Business Overview
    • 13.10.3 G & W Laboratories Inc. Psoriasis Therapeutics Introduction
    • 13.10.4 G & W Laboratories Inc. Revenue in Psoriasis Therapeutics Business (2015-2020)
    • 13.10.5 G & W Laboratories Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Summary:
    Get latest Market Research Reports on Psoriasis Therapeutics . Industry analysis & Market Report on Psoriasis Therapeutics is a syndicated market report, published as Global Psoriasis Therapeutics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Psoriasis Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,088.80
    4,633.20
    6,177.60
    3,603.60
    5,405.40
    7,207.20
    590,031.00
    885,046.50
    1,180,062.00
    325,143.00
    487,714.50
    650,286.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report